DNA Double-Strand Break Repair by Non-homologous End Joining and Its Clinical Relevance

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1016/B978-0-12-384999-1.10008-3
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Advances in the Treatment of Testicular Cancer

  2012cited by this paper
• Widespread dependence of backup NHEJ on growth state: ramifications for the use of DNA-PK inhibitors.

  2011cited by this paper
• Mitoxantrone in combination with an inhibitor of DNA‐dependent protein kinase: a potential therapy for high risk B‐cell chronic lymphocytic leukaemia

  2011cited by this paper
• Ataxia telangiectasia mutated (Atm) and DNA-PKcs kinases have overlapping activities during chromosomal signal joint formation

  2011cited by this paper
• Factors determining DNA double‐strand break repair pathway choice in G2 phase

  2011cited by this paper
• Inhibition of Homologous Recombination by DNA-Dependent Protein Kinase Requires Kinase Activity, Is Titratable, and Is Modulated by Autophosphorylation

  2011cited by this paper
• Ataxia telangiectasia-mutated protein and DNA-dependent protein kinase have complementary V(D)J recombination functions

  2011cited by this paper
• Histone acetylation by CBP and p300 at double-strand break sites facilitates SWI/SNF chromatin remodeling and the recruitment of non-homologous end joining factors

  2011cited by this paper
• Coordination of DNA–PK Activation and Nuclease Processing of DNA Termini in NHEJ

  2011cited by this paper
• PARP-3 and APLF function together to accelerate nonhomologous end-joining.

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• Genetic variations of DNA repair genes and their prognostic significance in patients with acute myeloid leukemia

  2011cited by this paper
• Polymerases in Nonhomologous End Joining: Building a Bridge over Broken Chromosomes

  2011cited by this paper
• Clustered DNA lesion repair in eukaryotes: relevance to mutagenesis and cell survival.

  2011cited by this paper
• The PARP inhibitor olaparib induces significant killing of ATM-deficient lymphoid tumor cells in vitro and in vivo.

  2010cited by this paper
• End-processing during non-homologous end-joining: a role for exonuclease 1

  2010cited by this paper
• 6-thioguanine selectively kills BRCA2-defective tumors and overcomes PARP inhibitor resistance.

  2010cited by this paper
• Systematic review of benefits and risks of second-line irinotecan monotherapy for advanced colorectal cancer

  2010cited by this paper
• The MRN complex in double‐strand break repair and telomere maintenance

  2010cited by this paper
• MRE11 expression is predictive of cause-specific survival following radical radiotherapy for muscle-invasive bladder cancer.

  2010cited by this paper
• Rapid DNA–protein cross-linking and strand scission by an abasic site in a nucleosome core particle

  2010cited by this paper
• ATM is down-regulated by N-Myc–regulated microRNA-421

  2010cited by this paper
• Yeast Tdp1 regulates the fidelity of nonhomologous end joining

  2010cited by this paper
• The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Yeast Nej1 Is a Key Participant in the Initial End Binding and Final Ligation Steps of Nonhomologous End Joining*

  2010cited by this paper
• Investigation of DNA damage response and apoptotic gene methylation pattern in sporadic breast tumors using high throughput quantitative DNA methylation analysis technology

  2010cited by this paper
• Cellular strategies for regulating DNA supercoiling: a single-molecule perspective.

  2010cited by this paper
• Mre11-Rad50-Nbs1 conformations and the control of sensing, signaling, and effector responses at DNA double-strand breaks.

  2010cited by this paper
• ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors

  2010cited by this paper
• Nonhomologous DNA end joining (NHEJ) and chromosomal translocations in humans.

  2010cited by this paper
• A structural model for regulation of NHEJ by DNA-PKcs autophosphorylation.

  2010cited by this paper
• Dual Modes of Interaction between XRCC4 and Polynucleotide Kinase/Phosphatase

  2010cited by this paper
• ATM-Dependent and -Independent Dynamics of the Nuclear Phosphoproteome After DNA Damage

  2010cited by this paper
• Site-specific Phosphorylation Dynamics of the Nuclear Proteome during the DNA Damage Response*

  2010cited by this paper
• Targeting DNA-PKcs and ATM with miR-101 Sensitizes Tumors to Radiation

  2010cited by this paper
• Modulation of mismatch repair and genomic stability by miR-155

  2010cited by this paper
• The ACF1 complex is required for DNA double-strand break repair in human cells.

  2010cited by this paper
• Homologous recombination as a resistance mechanism to replication-induced double-strand breaks caused by the antileukemia agent CNDAC.

  2010cited by this paper
• Complexity and simplicity in the biosynthesis of enediyne natural products.

  2010cited by this paper
• XLF regulates filament architecture of the XRCC4·ligase IV complex.

  2010cited by this paper
• Purification and characterization of exonuclease-free Artemis: Implications for DNA-PK-dependent processing of DNA termini in NHEJ-catalyzed DSB repair.

  2010cited by this paper
• ATM Damage Response and XLF Repair Factor are Functionally Redundant In Joining DNA Breaks

  2010cited by this paper
• Ku is a 5'dRP/AP lyase that excises nucleotide damage near broken ends

  2010cited by this paper
• The influence of heterochromatin on DNA double strand break repair: Getting the strong, silent type to relax.

  2010cited by this paper
• Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining.

  2009cited by this paper
• Ku and DNA-dependent Protein Kinase Dynamic Conformations and Assembly Regulate DNA Binding and the Initial Non-homologous End Joining Complex*

  2009cited by this paper
• Role of mammalian Mre11 in classical and alternative non-homologous end joining

  2009cited by this paper
• Essential role for DNA-PKcs in DNA double-strand break repair and apoptosis in ATM-deficient lymphocytes.

  2009cited by this paper
• hnRNP-U is a specific DNA-dependent protein kinase substrate phosphorylated in response to DNA double-strand breaks.

  2009cited by this paper
• Crystal Structure of DNA-PKcs Reveals a Large Open-Ring Cradle Comprised of HEAT Repeats

  2009cited by this paper
• Lung cancer susceptibility and genetic polymorphism of DNA repair gene XRCC4 in Taiwan

  2009cited by this paper
• Epigenetics and human disease.

  2009cited by this paper
• Gene-body hypermethylation of ATM in peripheral blood DNA of bilateral breast cancer patients

  2009cited by this paper
• Identification of a small molecule inhibitor of the human DNA repair enzyme polynucleotide kinase/phosphatase.

  2009cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• DNA topoisomerase I inhibitors: chemistry, biology, and interfacial inhibition.

  2009cited by this paper
• Significant association of ERCC6 single nucleotide polymorphisms with bladder cancer susceptibility in Taiwan.

  2009cited by this paper
• Tyrosyl-DNA phosphodiesterase and the repair of 3'-phosphoglycolate-terminated DNA double-strand breaks.

  2009cited by this paper
• Recurrent genomic alterations characterize medulloblastoma arising from DNA double-strand break repair deficiency

  2009cited by this paper
• New advances in the second-line treatment of small cell lung cancer.

  2009cited by this paper
• Mechanism of Action of an Imidopiperidine Inhibitor of Human Polynucleotide Kinase/Phosphatase*

  2009cited by this paper
• MicroRNAs: Target Recognition and Regulatory Functions

  2009cited by this paper
• Cell nonhomologous end joining capacity controls SAF-A phosphorylation by DNA-PK in response to DNA double-strand breaks inducers

  2009cited by this paper
• Genetic variation in DNA repair pathway genes and premenopausal breast cancer risk

  2009cited by this paper
• Mechanism of DNA substrate recognition by the mammalian DNA repair enzyme, Polynucleotide Kinase

  2009cited by this paper
• Sequence Variant Discovery in DNA Repair Genes from Radiosensitive and Radiotolerant Prostate Brachytherapy Patients

  2009cited by this paper
• Current role and future aspects of topotecan in relapsed ovarian cancer

  2009cited by this paper
• Targeting DNA topoisomerase II in cancer chemotherapy

  2009cited by this paper
• Emerging common themes in regulation of PIKKs and PI3Ks

  2009cited by this paper
• Lung cancer susceptibility and prognosis associated with polymorphisms in the nonhomologous end‐joining pathway genes

  2009cited by this paper
• ATM and Artemis promote homologous recombination of radiation-induced DNA double-strand breaks in G2

  2009cited by this paper
• Structural and Functional Interaction between the Human DNA Repair Proteins DNA Ligase IV and XRCC4

  2009cited by this paper
• CMC-544 (inotuzumab ozogamicin), an anti-CD22 immuno-conjugate of calicheamicin, alters the levels of target molecules of malignant B-cells

  2009cited by this paper
• Bleomycin treatment of brain tumors: an evaluation.

  2009cited by this paper
• 14-3-3 proteins, FHA domains and BRCT domains in the DNA damage response.

  2009cited by this paper
• Two brothers with ataxia-telangiectasia-like disorder with lung adenocarcinoma.

  2009cited by this paper
• Acute normal tissue reactions in head-and-neck cancer patients treated with IMRT: influence of dose and association with genetic polymorphisms in DNA DSB repair genes.

  2009cited by this paper
• DNA Double Strand Break Repair: Mechanisms and Therapeutic Potential

  2009cited by this paper
• BRCT domains: phosphopeptide binding and signaling modules.

  2008cited by this paper
• Lymphocyte-specific compensation for XLF/cernunnos end-joining functions in V(D)J recombination.

  2008cited by this paper
• Polymorphisms in nonhomologous end‐joining genes associated with breast cancer risk and chromosomal radiosensitivity

  2008cited by this paper
• Multiple-treatments meta-analysis of chemotherapy and targeted therapies in advanced breast cancer.

  2008cited by this paper
• Polynucleotide kinase as a potential target for enhancing cytotoxicity by ionizing radiation and topoisomerase I inhibitors.

  2008cited by this paper
• The endless tale of non-homologous end-joining

  2008cited by this paper
• Flexibility in the order of action and in the enzymology of the nuclease, polymerases, and ligase of vertebrate non-homologous DNA end joining: relevance to cancer, aging, and the immune system

  2008cited by this paper
• A DNA-PKcs mutation in a radiosensitive T-B- SCID patient inhibits Artemis activation and nonhomologous end-joining.

  2008cited by this paper
• Eukaryotic DNA ligases: structural and functional insights.

  2008cited by this paper
• A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair.

  2008cited by this paper
• Expression status of ataxia-telangiectasia-mutated gene correlated with prognosis in advanced gastric cancer.

  2008cited by this paper
• The Mechanism of Human Nonhomologous DNA End Joining*

  2008cited by this paper
• Modern treatment of Hodgkin lymphoma

  2008cited by this paper
• Non-homologous end joining is the responsible pathway for the repair of fludarabine-induced DNA double strand breaks in mammalian cells.

  2008cited by this paper
• Live cell imaging of XLF and XRCC4 reveals a novel view of protein assembly in the non-homologous end-joining pathway

  2008cited by this paper
• Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer

  2008cited by this paper
• Unique morphological spectrum of lymphomas in Nijmegen breakage syndrome (NBS) patients with high frequency of consecutive lymphoma formation

  2008cited by this paper
• XLF-Cernunnos promotes DNA ligase IV–XRCC4 re-adenylation following ligation

  2008cited by this paper
• Ku80 removal from DNA through double strand break–induced ubiquitylation

  2008cited by this paper
• The chemical toxicology of 2-deoxyribose oxidation in DNA.

  2008cited by this paper
• Ku70 predicts response and primary tumor recurrence after therapy in locally advanced head and neck cancer

  2008cited by this paper

• Selective Targeting to Glioma with Nucleic Acid Aptamers

  2015cites this paper
• Proteomic Identification of DNA-PK Involvement within the RET Signaling Pathway

  2015cites this paper
• Organization and dynamics of the nonhomologous end-joining machinery during DNA double-strand break repair

  2015cites this paper
• Targeting DNA repair pathways for cancer treatment: what's new?

  2014cites this paper
• Detection and repair of ionizing radiation-induced DNA double strand breaks: new developments in nonhomologous end joining.

  2013cites this paper